HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temodar offers promise for treating astrocytomas.

Abstract
Temodar is an exciting new drug that shows promise in the treatment of brain tumors as well as in other types of cancers. Research currently is being conducted with Temodar to determine its efficacy in treating various solid tumors, glioblastoma multiform, and even metastatic melanoma. Temodar provides adult patients with anaplastic astrocytoma with another option of therapy that is convenient, produces minimal side effects, and, above all, instills hope.
AuthorsT Armstrong, C Hancock
JournalClinical journal of oncology nursing (Clin J Oncol Nurs) 2000 Jul-Aug Vol. 4 Issue 4 Pg. 159-60 ISSN: 1092-1095 [Print] United States
PMID11261095 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide
Topics
  • Algorithms
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Astrocytoma (drug therapy)
  • Brain Neoplasms (blood, drug therapy)
  • Dacarbazine (analogs & derivatives, therapeutic use)
  • Decision Trees
  • Drug Administration Schedule
  • Drug Monitoring
  • Humans
  • Leukocyte Count
  • Neutrophils
  • Patient Education as Topic
  • Platelet Count
  • Temozolomide
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: